280 related articles for article (PubMed ID: 7716789)
1. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
2. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
[TBL] [Abstract][Full Text] [Related]
3. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
Bjørklund G; Mutter J; Aaseth J
Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined chelation in lead intoxication.
Tandon SK; Singh S; Jain VK
Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
[TBL] [Abstract][Full Text] [Related]
5. DMSA, DMPS, and DMPA--as arsenic antidotes.
Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
[TBL] [Abstract][Full Text] [Related]
6. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
[TBL] [Abstract][Full Text] [Related]
7. Human studies with the chelating agents, DMPS and DMSA.
Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
[TBL] [Abstract][Full Text] [Related]
8. DMSA and DMPS--water soluble antidotes for heavy metal poisoning.
Aposhian HV
Annu Rev Pharmacol Toxicol; 1983; 23():193-215. PubMed ID: 6307120
[No Abstract] [Full Text] [Related]
9. Arsenic and lead induced free radical generation and their reversibility following chelation.
Flora SJ; Flora G; Saxena G; Mishra M
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
[TBL] [Abstract][Full Text] [Related]
10. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
Inns RH; Rice P
Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
[TBL] [Abstract][Full Text] [Related]
12. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
Zalups RK; Bridges CC
Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
[TBL] [Abstract][Full Text] [Related]
14. The role of chelation in the treatment of arsenic and mercury poisoning.
Kosnett MJ
J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
[TBL] [Abstract][Full Text] [Related]
15. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
[TBL] [Abstract][Full Text] [Related]
16. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
17. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
Aposhian HV; Aposhian MM
Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
[TBL] [Abstract][Full Text] [Related]
18. Chelation therapy in intoxications with mercury, lead and copper.
Cao Y; Skaug MA; Andersen O; Aaseth J
J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
[TBL] [Abstract][Full Text] [Related]
19. Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein.
Zheng W; Maiorino RM; Brendel K; Aposhian HV
Fundam Appl Toxicol; 1990 Apr; 14(3):598-607. PubMed ID: 2160390
[TBL] [Abstract][Full Text] [Related]
20. [Metal poisoning].
Ferrer A
An Sist Sanit Navar; 2003; 26 Suppl 1():141-53. PubMed ID: 12813482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
